Showing results (171-180 of 259) with videos related to
Sort By:
Pageof 26
Cancer Chemotherapy and Pharmacology|January 1, 1988
Uridine pharmacokinetics in cancer patientsT C Chan, M Markman, C E Pfeifle, et al.British Journal of Cancer|September 20, 2000
Identification of genes differentially expressed in association with acquired cisplatin resistanceA Johnsson, I Zeelenberg, Y Min, et al.Cancer Research|April 1, 1993
Prolongation of drug exposure in cerebrospinal fluid by encapsulation into DepoFoamS Kim, S Khatibi, S B Howell, et al.Archives of Neurology|March 1, 1993
Treatment of leptomeningeal metastasis with intraventricular administration of depot cytarabine (DTC 101). A phase I studyM C Chamberlain, S Khatibi, J C Kim, et al.Cancer Research|July 1, 1997
Synergy between tamoxifen and cisplatin in human melanoma cells is dependent on the presence of antiestrogen-binding sitesJ A Jones, K D Albright, R D Christen, et al.British Journal of Cancer|March 1, 1993
Selective modulation of vinblastine sensitivity by 1,9-dideoxyforskolin and related diterpenes in multidrug resistant tumour cellsD R Shalinsky, D D Heath, A P Jekunen, et al.Head & Neck|September 1, 1992
Rapid superselective high-dose cisplatin infusion for advanced head and neck malignanciesK T Robbins, A M Storniolo, C Kerber, et al.Cancer Drug Delivery|January 1, 1986
Pharmacologic studies of intra-hepatic artery chemotherapy with degradable starch microspheresC E Pfeifle, S B Howell, W L Ashburn, et al.British Journal of Cancer|December 1, 1994
Induction of the growth arrest and DNA damage-inducible gene GADD153 by cisplatin in vitro and in vivoD P Gately, J A Jones, R Christen, et al.Journal of the National Cancer Institute|October 18, 1989
Effect of sodium thiosulfate on the pharmacokinetics and toxicity of cisplatinR Goel, S M Cleary, C Horton, et al.Pageof 26